{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:12:29Z","timestamp":1778850749481,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.resinv.2026.101422","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:22:14Z","timestamp":1775791334000},"page":"101422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical evidence on BCG vaccination and COVID-19 infection: A systematic review"],"prefix":"10.1016","volume":"64","author":[{"given":"Praneta","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arpita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9795-5641","authenticated-orcid":false,"given":"Devendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.resinv.2026.101422_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0321511","article-title":"Efficacy of BCG vaccination against COVID-19 in health care workers and non-health care workers: a meta-analysis of randomized controlled trials","volume":"20","author":"Xia","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101422_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.632478","article-title":"The BCG vaccine for COVID-19: first verdict and future directions","volume":"12","author":"Gonzalez-Perez","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib3","article-title":"Variances in BCG protection against COVID-19 mortality: a global assessment","volume":"24","author":"Sarfraz","year":"2021","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"issue":"1","key":"10.1016\/j.resinv.2026.101422_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/joim.20033","article-title":"Therapeutic BCG vaccine protects against long COVID: the BATTLE randomized clinical trial","volume":"297","author":"Jalalizadeh","year":"2025","journal-title":"J Intern Med"},{"issue":"17","key":"10.1016\/j.resinv.2026.101422_bib5","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJMoa2212616","article-title":"Randomized trial of BCG vaccine to protect against Covid-19 in health care workers","volume":"388","author":"Pittet","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.resinv.2026.101422_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00356-23","article-title":"BCG vaccination of health care workers does not reduce SARS-CoV-2 infections nor infection severity or duration: a randomized placebo-controlled trial","volume":"14","author":"Claus","year":"2023","journal-title":"mBio"},{"issue":"3","key":"10.1016\/j.resinv.2026.101422_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2007-1014662","article-title":"Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence","volume":"21","author":"Maarbjerg","year":"1988","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.resinv.2026.101422_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841868","article-title":"Efficacy and safety of BCG revaccination with M. bovis BCG Moscow to prevent COVID-19 infection in health care workers: a randomized phase II clinical trial","volume":"13","author":"Dos Anjos","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03447-20","article-title":"MMR vaccine and COVID-19: measles protein homology may contribute to cross-reactivity or to complement activation protection","volume":"12","author":"Marakasova","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.resinv.2026.101422_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijid.2023.02.014","article-title":"The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil","volume":"130","author":"Santos","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101422_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126911","article-title":"Efficacy of BCG vaccination on incidence, severity and clinical progression of COVID-19: a BCG-REVAC population analysis","volume":"54","author":"de Souza","year":"2025","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.resinv.2026.101422_bib12","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/joim.13523","article-title":"Randomized clinical trial of BCG vaccine in patients with convalescent COVID-19: clinical evolution, adverse events, and humoral immune response","volume":"292","author":"Jalalizadeh","year":"2022","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.resinv.2026.101422_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/joim.20033","article-title":"Therapeutic BCG vaccine protects against long COVID: the BATTLE randomized clinical trial","volume":"297","author":"Jalalizadeh","year":"2025","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.resinv.2026.101422_bib14","first-page":"424","article-title":"Rekonstrukcja dr\u00f3g \u0142zowych po uszkodzeniach urazowych. II. Wyniki [reconstruction of the lacrimal apparatus after injury. II. Results]","volume":"88","author":"Gluza","year":"1986","journal-title":"Klin Oczna"},{"issue":"6","key":"10.1016\/j.resinv.2026.101422_bib15","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s40121-022-00703-y","article-title":"Efficacy of bacillus Calmette-Gu\u00e9rin (BCG) vaccination in reducing the incidence and severity of COVID-19 in high-risk population (BRIC): a phase III, multi-centre, quadruple-blind randomised control trial","volume":"11","author":"Sinha","year":"2022","journal-title":"Infect Dis Ther"},{"issue":"6284","key":"10.1016\/j.resinv.2026.101422_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"6204","key":"10.1016\/j.resinv.2026.101422_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.resinv.2026.101422_bib18","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"10.1016\/j.resinv.2026.101422_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","article-title":"BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis","volume":"172","author":"Kaufmann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.resinv.2026.101422_bib20","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2026.101422_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The humoral immune response to BCG vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.resinv.2026.101422_bib23","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/infdis\/jiz692","article-title":"Trained immunity confers broad-spectrum protection against bacterial infections","volume":"222","author":"Ciarlo","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.resinv.2026.101422_bib24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000355628","article-title":"Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity","volume":"6","author":"Kleinnijenhuis","year":"2014","journal-title":"J Innate Immun"},{"issue":"2","key":"10.1016\/j.resinv.2026.101422_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","volume":"28","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.resinv.2026.101422_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.985938","article-title":"Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD\u2122 vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults","volume":"13","author":"Rakshit","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.812176","article-title":"Large-scale structure-based screening of potential T cell cross-reactivities involving peptide-targets from BCG vaccine and SARS-CoV-2","volume":"12","author":"Tarabini","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.resinv.2026.101422_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"41","key":"10.1016\/j.resinv.2026.101422_bib29","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1016\/j.vaccine.2020.08.045","article-title":"BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: in silico analyses and a hypothesis","volume":"38","author":"Tomita","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.resinv.2026.101422_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.692729","article-title":"BCG vaccine derived peptides induce SARS-CoV-2 T cell cross-reactivity","volume":"12","author":"Eggenhuizen","year":"2021","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.resinv.2026.101422_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302722","article-title":"BCG activation of trained immunity is associated with induction of cross reactive COVID-19 antibodies in a BCG vaccinated population","volume":"19","author":"Iqbal","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.resinv.2026.101422_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102616","article-title":"Bacille Calmette-Gu\u00e9rin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial","volume":"72","author":"Pittet","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.resinv.2026.101422_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101414","article-title":"Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: a double-blind, randomised, controlled, phase 3 trial","volume":"48","author":"Upton","year":"2022","journal-title":"eClinicalMedicine"},{"issue":"1","key":"10.1016\/j.resinv.2026.101422_bib34","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1093\/cid\/ciac182","article-title":"Efficacy of BCG vaccination against respiratory tract infections in older adults during the coronavirus disease 2019 pandemic","volume":"75","author":"Moorlag","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.resinv.2026.101422_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106319","article-title":"Evaluating the effect of BCG vaccination for non-specific protection from infection in senior citizens during the COVID-19 pandemic: a randomised clinical trial","volume":"89","author":"Madsen","year":"2024","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.resinv.2026.101422_bib36","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.cmi.2023.01.019","article-title":"Bacillus Calmette-Gu\u00e9rin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults with comorbidities: a randomized controlled trial","volume":"29","author":"Koekenbier","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2026.101422_bib37","article-title":"ACTIVATE-2: a double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk","volume":"13","author":"Tsilika","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.resinv.2026.101422_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106245","article-title":"BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial","volume":"89","author":"Messina","year":"2024","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.resinv.2026.101422_bib39","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/jcm12031154","article-title":"Efficacy of BCG vaccination against COVID-19: systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Wen","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.resinv.2026.101422_bib40","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2026.101422_bib41","first-page":"171","article-title":"About training and memory. Advances in immunology","volume":"133","author":"Hammer","year":"2017","journal-title":"Elsevier"},{"issue":"7","key":"10.1016\/j.resinv.2026.101422_bib42","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.3390\/vaccines10071006","article-title":"Fiction and facts about BCG imparting trained immunity against COVID-19","volume":"10","author":"Kaur","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"41","key":"10.1016\/j.resinv.2026.101422_bib43","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1016\/j.vaccine.2020.08.018","article-title":"The effect of Bacillus Calmette-Gu\u00e9rin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: implications for the COVID-19 pandemic","volume":"38","author":"Yitbarek","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.resinv.2026.101422_bib44","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3143\/geriatrics.42.34","article-title":"[Prevention of elderly pneumonia by pneumococcal, influenza and BCG vaccinations]","volume":"42","author":"Ohrui","year":"2005","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"10.1016\/j.resinv.2026.101422_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08830185.2021.1922685","article-title":"Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic","volume":"41","author":"Aspatwar","year":"2022","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib46","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.resinv.2026.101422_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103656","article-title":"Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: kinetics and durability of the humoral immune response","volume":"73","author":"Onta\u00f1\u00f3n","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.resinv.2026.101422_bib48","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant Bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.resinv.2026.101422_bib49","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s000180050284","article-title":"Ion channels in plant signaling","volume":"55","author":"Zimmermann","year":"1999","journal-title":"CMLS Cell Mol Life Sci"},{"key":"10.1016\/j.resinv.2026.101422_bib50","article-title":"Intravenous administration of BCG protects mice against lethal SARS-CoV-2 challenge","volume":"219","author":"Hilligan","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.resinv.2026.101422_bib51","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.urolonc.2008.12.017","article-title":"The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer","volume":"28","author":"Andrade","year":"2010","journal-title":"Urol Oncol: Seminars and Original Investigations"},{"key":"10.1016\/j.resinv.2026.101422_bib52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vaccine.2020.12.026","article-title":"BCG vaccine: worrying proposal for COVID-19","volume":"39","author":"Sarinho","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.resinv.2026.101422_bib53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijtb.2020.10.012","article-title":"Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?","volume":"68","author":"Gong","year":"2021","journal-title":"Indian J Tubercul"},{"key":"10.1016\/j.resinv.2026.101422_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1186\/s13063-020-04714-3","article-title":"Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: a structured summary of a study protocol for a randomised controlled trial in Denmark","volume":"21","author":"Madsen","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.resinv.2026.101422_bib55","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1016\/j.vaccine.2007.01.087","article-title":"Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine","volume":"25","author":"Dennehy","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.resinv.2026.101422_bib56","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s13063-020-04822-0","article-title":"BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Junqueira-Kipnis","year":"2020","journal-title":"Trials"},{"key":"10.1016\/j.resinv.2026.101422_bib57","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.resinv.2026.101422_bib58","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.resinv.2026.101422_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O'Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.resinv.2026.101422_bib60","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.immuni.2024.07.021","article-title":"BCG vaccination alters the epigenetic landscape of progenitor cells in human bone marrow to influence innate immune responses","volume":"57","author":"Sun","year":"2024","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.resinv.2026.101422_bib61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.resinv.2026.101422_bib62","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.chom.2023.05.004","article-title":"The role of trained immunity in COVID-19: lessons for the next pandemic","volume":"31","author":"Netea","year":"2023","journal-title":"Cell Host Microbe"},{"issue":"10","key":"10.1016\/j.resinv.2026.101422_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107733","article-title":"Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells","volume":"26","author":"Singh","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.resinv.2026.101422_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151600","article-title":"Strong homology between SARS-CoV-2 envelope protein and a mycobacterium sp. antigen allows rapid diagnosis of mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine","volume":"48","author":"Nuovo","year":"2020","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1016\/j.resinv.2026.101422_bib65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2020.08.051","article-title":"Activate: randomized clinical trial of BCG vaccination against infection in the elderly","volume":"183","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.resinv.2026.101422_bib66","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14760584.2021.1938550","article-title":"COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials","volume":"20","author":"Gong","year":"2021","journal-title":"Expert Rev Vaccines"},{"issue":"44","key":"10.1016\/j.resinv.2026.101422_bib67","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1016\/j.vaccine.2023.09.031","article-title":"Healthcare workers (HCWs) and non-HCWs reaction to Bacillus Calmette-Gu\u00e9rin (BCG) in the BATTLE trial","volume":"41","author":"Jalalizadeh","year":"2023","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.resinv.2026.101422_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38085","article-title":"The BCG vaccine and SARS-CoV-2: could there be a beneficial relationship?","volume":"10","author":"Pe\u00f1a-Bates","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.resinv.2026.101422_bib69","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/vaccines10050827","article-title":"Recombinant BCG to enhance its immunomodulatory activities","volume":"10","author":"Kowalewicz-Kulbat","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.resinv.2026.101422_bib70","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.resinv.2026.101422_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2018.00029","article-title":"Adjuvant effect of Bacille Calmette-Gu\u00e9rin on Hepatitis B vaccine immunogenicity in the preterm and term newborn","volume":"9","author":"Scheid","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-02728-4","article-title":"Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization","volume":"4","author":"Zhang","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.resinv.2026.101422_bib73","article-title":"Covid-19: single vaccine dose is 33% effective against variant from India, data show","volume":"373","author":"Iacobucci","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.resinv.2026.101422_bib74","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and immunogenicity of the recombinant Mycobacterium bovis BCG vaccine VPM1002 in HIV-unexposed newborn infants in South Africa","volume":"24","author":"Loxton","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib75","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3389\/fimmu.2017.01147","article-title":"The recombinant Bacille Calmette-Gu\u00e9rin vaccine VPM1002: ready for clinical efficacy testing","volume":"8","author":"Nieuwenhuizen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2026.101422_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102761","article-title":"Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential","volume":"55","author":"P\u00e9rez","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.resinv.2026.101422_bib77","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1586\/14760584.2014.905746","article-title":"The BCG replacement vaccine VPM1002: from drawing board to clinical trial","volume":"13","author":"Kaufmann","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.resinv.2026.101422_bib78","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1590\/S0100-879X2012007500142","article-title":"Recombinant vaccines and the development of new vaccine strategies","volume":"45","author":"Nascimento","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.resinv.2026.101422_bib79","first-page":"229","article-title":"Efficacy and safety of live recombinant BCG vaccines","volume":"84","author":"Hanson","year":"1995","journal-title":"Dev Biol Stand"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534526000560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:59:42Z","timestamp":1778849982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534526000560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2212534526000560"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101422","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evidence on BCG vaccination and COVID-19 infection: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2026.101422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101422"}}